Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas Article

Lamborn, Kathleen R, Yung, WK Alfred, Chang, Susan M et al. (2008). Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas . NEURO-ONCOLOGY, 10(2), 162-170. 10.1215/15228517-2007-062

Open Access

cited authors

  • Lamborn, Kathleen R; Yung, WK Alfred; Chang, Susan M; Wen, Patrick Y; Cloughesy, Timothy F; DeAngelis, Lisa M; Robins, H Ian; Lieberman, Frank S; Fine, Howard A; Fink, Karen L; Junck, Larry; Abrey, Lauren; Gilbert, Mark R; Mehta, Minesh; Kuhn, John G; Aldape, Kenneth D; Hibberts, Janelle; Peterson, Pamela M; Prados, Michael D

sustainable development goals

authors

publication date

  • April 1, 2008

webpage

published in

keywords

  • Clinical Neurology
  • GLIOBLASTOMA-MULTIFORME
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • PHASE-II
  • Science & Technology
  • TRIALS
  • brain tumors
  • clinical trial end points
  • glioma
  • progression-free survival

Digital Object Identifier (DOI)

publisher

  • DUKE UNIV PRESS

start page

  • 162

end page

  • 170

volume

  • 10

issue

  • 2